ChemioCare Inc., a pharmaceutical company working on a proprietary transdermal delivery platform, has closed a private round of financing, raising $★Research Note – Subscriber ONLY content: read our research and get insight on this and other deals. We offer monthly or yearly recurring or one-time trial subscriptions. Subscribe today and see what you have been missing! ★
ChemioCare’s Vision is to transform current treatment of chemotherapy-induced nausea and vomiting through patch technology.
New York City and Vancouver based based ChemioCare is a newly formed BC company.
photo credit: ChemioCare